Literature DB >> 7073246

Association between rise in serum sodium and central pontine myelinolysis.

M D Norenberg, K O Leslie, A S Robertson.   

Abstract

Twelve hyponatremic patients with central pontine myelinolysis (CPM) showed a rise in serum sodium levels 3 to 10 days (mean, 6) prior to the development of CPM. The increase exceeded 20 mEq/L within 1 to 3 days and was then sustained for an additional 3 to 5 days. In addition, 11 of the 12 CPM patients achieved a sodium value of 147 mEq/L or greater during the period of sodium elevation. The rise in sodium frequently coincided with administration of saline solutions, diuretics, steroids, and lactulose. In contrast, 9 hyponatremic patients who did not have CPM showed sodium increases that were significantly less or slower (or both) following treatment of hyponatremia. Our findings suggest that CPM may be caused by a too rapid or excessive rise in serum sodium from a hyponatremic baseline.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7073246     DOI: 10.1002/ana.410110204

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  51 in total

1.  Wernicke's encephalopathy and central pontine myelinolysis associated with hyperemesis gravidarum.

Authors:  P S Bergin; P Harvey
Journal:  BMJ       Date:  1992-08-29

2.  Diffuse demyelinating lesions of the brain after the rapid development of hypernatremia.

Authors:  W R Clark
Journal:  West J Med       Date:  1992-11

Review 3.  [Central pontine myelosis. Morphology and forensic importance].

Authors:  H Bratzke; K Neumann
Journal:  Z Rechtsmed       Date:  1989

4.  Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia.

Authors:  Haruyuki Suzuki; Yoshihisa Sugimura; Shintaro Iwama; Hiromi Suzuki; Ozaki Nobuaki; Hiroshi Nagasaki; Hiroshi Arima; Makoto Sawada; Yutaka Oiso
Journal:  J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 10.121

5.  Central pontine myelinolysis: historical and mechanistic considerations.

Authors:  Michael D Norenberg
Journal:  Metab Brain Dis       Date:  2010-02-25       Impact factor: 3.584

6.  Neurological complications associated with parenteral treatment: central pontine myelinolysis and Wernicke's encephalopathy.

Authors:  P D Thompson; R F Gledhill; N P Quinn; M N Rossor; P Stanley; E N Coomes
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-08

Review 7.  Preventing neurological complications from dysnatremias in children.

Authors:  Michael L Moritz; J Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2005-08-04       Impact factor: 3.714

8.  Role of organic osmolytes in myelinolysis. A topographic study in rats after rapid correction of hyponatremia.

Authors:  Y H Lien
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Management of hyponatremia in various clinical situations.

Authors:  Michael L Moritz; Juan C Ayus
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

10.  Osmotic regulation of myo-inositol uptake in primary astrocyte cultures.

Authors:  R E Isaacks; A S Bender; C Y Kim; N M Prieto; M D Norenberg
Journal:  Neurochem Res       Date:  1994-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.